Vision of a near future: Bridging the human health-environment divide. Toward an integrated strategy to understand mechanisms across species for chemical safety assessment.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 21 06 2019
revised: 25 09 2019
accepted: 14 10 2019
pubmed: 2 11 2019
medline: 9 6 2020
entrez: 1 11 2019
Statut: ppublish

Résumé

There is a growing recognition that application of mechanistic approaches to understand cross-species shared molecular targets and pathway conservation in the context of hazard characterization, provide significant opportunities in risk assessment (RA) for both human health and environmental safety. Specifically, it has been recognized that a more comprehensive and reliable understanding of similarities and differences in biological pathways across a variety of species will better enable cross-species extrapolation of potential adverse toxicological effects. Ultimately, this would also advance the generation and use of mechanistic data for both human health and environmental RA. A workshop brought together representatives from industry, academia and government to discuss how to improve the use of existing data, and to generate new NAMs data to derive better mechanistic understanding between humans and environmentally-relevant species, ultimately resulting in holistic chemical safety decisions. Thanks to a thorough dialogue among all participants, key challenges, current gaps and research needs were identified, and potential solutions proposed. This discussion highlighted the common objective to progress toward more predictive, mechanistically based, data-driven and animal-free chemical safety assessments. Overall, the participants recognized that there is no single approach which would provide all the answers for bridging the gap between mechanism-based human health and environmental RA, but acknowledged we now have the incentive, tools and data availability to address this concept, maximizing the potential for improvements in both human health and environmental RA.

Identifiants

pubmed: 31669395
pii: S0887-2333(19)30472-2
doi: 10.1016/j.tiv.2019.104692
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104692

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Claudia Rivetti (C)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Timothy E H Allen (TEH)

Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.

James B Brown (JB)

Department of Genome Dynamics Lawrence Berkeley National Laboratory, University of California Berkeley, Berkeley, California 94720, USA.

Emma Butler (E)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Paul L Carmichael (PL)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

John K Colbourne (JK)

School of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.

Matthew Dent (M)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Francesco Falciani (F)

Institute for Integrative Biology, University of Liverpool, L69 7ZB Liverpool, United Kingdom.

Lina Gunnarsson (L)

Biosciences, College of Life and Environmental Sciences, University of Exeter, Geoffrey Pope, Stocker Road, Exeter, Devon EX4 4QD, United Kingdom.

Steve Gutsell (S)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Joshua A Harrill (JA)

National Center for Computational Toxicology, Office of Research & Development, U.S. Environmental Protection Agency, Mail Code B205-01, Research Triangle Park, Durham, North Carolina 27711, USA.

Geoff Hodges (G)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Paul Jennings (P)

Division of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Richard Judson (R)

National Center for Computational Toxicology, Office of Research & Development, U.S. Environmental Protection Agency, Mail Code B205-01, Research Triangle Park, Durham, North Carolina 27711, USA.

Aude Kienzler (A)

European Commission, Joint Research Centre (JRC), Ispra, VA, Italy.

Luigi Margiotta-Casaluci (L)

College of Health and Life Sciences, Brunel University London, London UB8 3PH, United Kingdom.

Iris Muller (I)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Stewart F Owen (SF)

AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TF, United Kingdom.

Cecilie Rendal (C)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Paul J Russell (PJ)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Sharon Scott (S)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Fiona Sewell (F)

NC3Rs, Gibbs Building, 215 Euston Road, London NW1 2BE, United Kingdom.

Imran Shah (I)

National Center for Computational Toxicology, Office of Research & Development, U.S. Environmental Protection Agency, Mail Code B205-01, Research Triangle Park, Durham, North Carolina 27711, USA.

Ian Sorrel (I)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Mark R Viant (MR)

School of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.

Carl Westmoreland (C)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Andrew White (A)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom.

Bruno Campos (B)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, United Kingdom. Electronic address: Bruno.Campos@Unilever.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH